Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Actavis Inc       US9426831031

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ACTAVIS INC
02/04DJAllergan Profit Surges On Higher Sales Ahead Of Actavis Takeover
02/04 ACTAVIS : Announces FDA Acceptance of sNDA to Expand TEFLARO® (ceftaroline fosam..
02/03 How the Actavis deal upended Allergan No. 2's CEO ambitions
02/03DJMitsubishi UFJ Saw 18% Rise In April-Dec Profit Boosted By Overseas Business-..
02/03DJMitsubishi UFJ Saw 18% Rise In April-Dec Profit Boosted By Overseas Business-..
01/31 ACTAVIS : Malta Operations appoint new Managing Director
01/31 ALLERGAN : SEC Labels Actavis Registration Statement for Pending Acquisition of ..
01/29DJValeant to Buy Prostate-Cancer Drug From Dendreon
01/29 Valeant to buy Dendreon's prostate cancer vaccine Provenge
01/29DJValeant in Deal to Buy Prostate-Cancer Drug Provenge From Dendreon
01/29 ACTAVIS : Malta Operations appoint new Managing Director
01/29 ACTAVIS : Entry into a Material Definitive Agreement, Other Events, Financial St..
01/29 ALLERGAN : SEC Labels Actavis Registration Statement for Pending Acquisition of ..
01/28 ACTAVIS : Richter and Actavis Announce Positive Phase III Results for Cariprazin..
01/28 ACTAVIS : to buy Auden Mckenzie for GBP306m
01/28 SHIRE : Says US Supreme Court Grants Its Petition In Lialda Patent Case
01/27 Still looking to buy, Pfizer revenue, profit hit by currency-exchange rates
01/27DJPfizer Hit by Stronger Dollar, Patent Losses, Lawsuit Settlement -- 3rd Updat..
01/27DJPfizer Hit by Stronger Dollar, Patent Losses -- 2nd Update
01/26 ACTAVIS : Registration Statement for Pending Acquisition of Allergan Declared Ef..
01/26DJActavis Buys Auden Mckenzie, to Become Largest UK Generic Supplier
01/26 ACTAVIS : to Acquire Auden Mckenzie for 306M GBP
01/23 ACTAVIS : Announces Exceptional Preliminary Fourth Quarter 2014 Performance
01/23 ACTAVIS : Launches U.S. Generic Specialty Injectable Portfolio
01/22 ACTAVIS : and Valeant raise prospect of more pharma deals
01/21DJHong Kong Tycoon Li Ka-shing's Watson to Buy Dirx
01/21 ALLERGAN : Actavis and Allergan Update on Early Halt to Hart-Scott-Rodino Waitin..
01/20 DEUTSCHE BANK : Reaffirms “Buy” Rating for Actavis plc (ACT)
01/20 ACTAVIS : MNCs recall drugs made in Indian plants
01/20 ACTAVIS : Richter and Actavis Announce Positive Phase III Results for Cariprazin..
01/17 ACTAVIS : Deutsche Bank Reiterates Buy Rating for Actavis plc (ACT)
01/15 ALLERGAN : Actavis and Allergan Update on Early Halt to Hart-Scott-Rodino Waitin..
01/14 ACTAVIS : and Gedeon Richter Announce FDA Receipt of NDA Resubmission for Caripr..
01/14 ACTAVIS : introduces US generic specialty injectable portfolio
01/14 ACTAVIS : Launches U.S. Generic Specialty Injectable Portfolio
01/14 ACTAVIS : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
01/13 ACTAVIS : Announces Exceptional Preliminary Fourth Quarter 2014 Performance
01/13 ACTAVIS : Launches U.S. Generic Specialty Injectable Portfolio
01/12DJActavis Expects Profit to Beat Expectations
01/12 ACTAVIS : Results of Operations and Financial Condition (form 8-K)
01/12 ACTAVIS : Announces Exceptional Preliminary Fourth Quarter 2014 Performance
01/12 ACTAVIS : Other Events, Financial Statements and Exhibits (form 8-K)
01/12 ACTAVIS : Adamas Pharmaceuticals Provides Review of 2014 and Previews Upcoming B..
01/12 ACTAVIS : and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting P..
01/08 ACTAVIS : Court to Decide Next Month on Actavis Tactic for its Alzheimer's Drug
01/07 ACTAVIS : Appeals court leaves intact Alzheimer's drug order
01/06 ACTAVIS : and Gedeon Richter Announce FDA Receipt of NDA Resubmission for Caripr..
01/01DJTo Last, M&A Boom Needs to Broaden
2014DJHedge Funds Stumble Over M&A in 2014
2014 ACTAVIS : Timing is Crucial, Upside Analysis: Research Reports on Alder, Sky Sol..
2014 ACTAVIS : Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose C..
2014 EXCLUSIVE : Express Scripts presses for more drug savings with coverage list
2014 M&A boom helps push investment banking fees to highest level since 2007
2014 ACTAVIS : Names Jonathon Kellerman Executive Vice President, Global Chief Compli..
2014 ACTAVIS : to Present at 33rd Annual J.P. Morgan Healthcare Conference
2014 ACTAVIS : XYDALBA(TM) (dalbavancin) Receives CHMP Positive Opinion for the Treat..
2014 ACTAVIS : to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
2014DJActavis CEO to Remain After Allergan Merger
2014DJBrent Saunders faces challenge of running combined Actavis-Allergan
2014 ACTAVIS : Launches Generic Version of Celebrex®
2014DJMerck Reaffirms Commitment to Cubist Deal Despite Patent Ruling -- Update
2014 Exclusive - Valeant to drop deal-making in near term to cut debt, boost stock
2014DJMerck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 6th Update
2014DJMerck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 5th Update
2014DJMerck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 4th Update
2014DJMerck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 3rd Update
2014 ACTAVIS : Anti-Infective Advisory Committee Recommends Approval Of Actavis' Ceft..
2014 ACTAVIS : Launches Generic Version of Intuniv®
2014 WILLIAM ACKMAN : Ackman's Pershing Square sees big payoff from Allergan deal
2014 Ackman's Pershing Square sees big payoff from Allergan deal
2014DJCEOS' TEST : Contending With Activist Investors
2014 ACTAVIS : Stock Updates on Pharma Services - Avanir Pharma, Zoetis, Allergan, Ma..
2014 ACTAVIS MULLS JOB CUTS, CHINA EXPANS : Bloomberg
2014 Valeant slashes stake in Allergan after losing bid
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF